Delaware is the US’s go-to venue for pharma patent litigation, but there could be trouble ahead
Reset password
Register to access two of our subscriber only articles per month.
Register
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Subscribe
Author | Life sciences reporter
[email protected]
@IAM_Alerts Brazilian Supreme Court set to decide the fate of tens of thousands of patents: https://t.co/25vWXBoPJh https://t.co/vhKVE3BiQ1 Read more
@IAM_Alerts One year after going private, Japanese patent fund is gearing up for SEP battles. https://t.co/3WSmbfwp0v https://t.co/WyMvcwqnO4 Read more
@IAM_Alerts Not necessary, necessarily; but definitely already possible. https://t.co/aXupMmMIus Read more
@IAM_Alerts Foreign patent filings decline in China in latest reversal of a long-term growth trend https://t.co/FK3Vx3Vid2 https://t.co/zwYCOoIZ4Q Read more
